Browsing Category

45130 posts
LRQA strengthens its commitment to Supply Chain Sustainability at the Asia Pacific Supply Chain Sustainability Summit 2025

LRQA strengthens its commitment to Supply Chain Sustainability at the Asia Pacific Supply Chain Sustainability Summit 2025

SINGAPORE, March 26, 2025 /PRNewswire/ — As stricter regulations, growing sustainable investment, and…
LRQA strengthens its commitment to Supply Chain Sustainability at the Asia Pacific Supply Chain Sustainability Summit 2025

LRQA strengthens its commitment to Supply Chain Sustainability at the Asia Pacific Supply Chain Sustainability Summit 2025

SINGAPORE, March 26, 2025 /PRNewswire/ — As stricter regulations, growing sustainable investment, and…

SEMIFIVE Achieves Over KRW 100 Billion in Revenue in 5 Years – Remarkable Year-over-Year Growth Rate of 57%

Built a differentiated portfolio and accelerated revenue growth with its independently developed…

TPIsoftware and Hua Nan Bank Partner to Elevate Financial Services with Digital Banking Platform

TAIPEI, March 26, 2025 /PRNewswire/ — TPIsoftware (TWSE: 7781), a leading B2B software…
Meta, Bauhaus, Lukfook Jewellery and SMCP unveiled WhatsApp and conversational AI strategies with Omnichat

Meta, Bauhaus, Lukfook Jewellery and SMCP unveiled WhatsApp and conversational AI strategies with Omnichat

Utilise WhatsApp as a strategic business channel to create personalised, real-time customer…

CStone to Showcase Five Latest Research Achievements at AACR 2025

SUZHOU, China, March 26, 2025 /PRNewswire/ — From April 25 to 30,…
GEEKOM IT13 2025 Edition Mini PC Unveiled: A Solid Upgrade Over the IT13

GEEKOM IT13 2025 Edition Mini PC Unveiled: A Solid Upgrade Over the IT13

TAIPEI, March 26, 2025 /PRNewswire/ — GEEKOM has introduced the latest addition…

NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

TEL AVIV, Israel, March 26, 2025 /PRNewswire/ — Neurim Pharmaceuticals ("Neurim") announces…